Arch Therapeutics Inc (ARTH)

Ticker: ARTH Exchange: OTC


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Hicks Laurence Non-Executive Director
Transaction date
Purchase
Price
468.43
Quantity 39,027 -43.5%
Value US$1,939,398
Norchi Terrence W PRESIDENT AND CHIEF EXECUTIVE Executive Director
Transaction date
Purchase
Price
270.10
Quantity 51,925 +47.8%
Value US$1,858,794
ABRAMS MICHAEL S CHIEF FINANCIAL OFFICER Officer
Transaction date
Purchase
Price
60.09
Quantity 81,923 -44.2%
Value US$3,886,809
SULAT JAMES R Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 111,111
Value US$0
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-09-08 2023-08-31 B Purchase Non-Executive Director
39,027 -43.5%
468.43
US$1,939,398
39,027 -43.5% 468.43 US$1,939,398
2023-09-08 2023-08-31 B Purchase

PRESIDENT AND CHIEF EXECUTIVE

Executive Director
51,925 +47.8%
270.10
US$1,858,794
51,925 +47.8% 270.10 US$1,858,794
2023-09-08 2023-08-31 B Purchase

CHIEF FINANCIAL OFFICER

Officer
81,923 -44.2%
60.09
US$3,886,809
81,923 -44.2% 60.09 US$3,886,809
2016-05-31 2016-05-26 B Purchase SULAT JAMES R Non-Executive Director
111,111
0.00
US$0
111,111 0.00 US$0